Cognition Therapeutics
ID: 5290945Cognition Therapeutics is a biotechnology and pharmaceutical company developing therapeutics for Alzheimer’s disease and other neurodegenerative disorders that is headquartered in Pittsburgh, Pennsylvania in 2007 by Gilbert Rishton and Susan Catalano.
4
Funding Rounds
$49.6m
Money raised
Recent Funding Rounds
Overview
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Gi***** M. Ri***** |
|
- | |
| Su*** Ca****** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja** A. Kh***** | - | - | |
| Aa*** Fl****** | - | - | - |
| Br*** P. Mo*** | - | - | |
| Li** Ri******* | - | - | - |
| Pe*** Wa***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Cognition Therapeutics has raised a total of $49.61m in funding over 4 rounds.
Key Insights:
- Cognition Therapeutics Initial public offering (IPO): $45.2m
- Cognition Therapeutics Series B round: $3m
- Cognition Therapeutics Series A round: $1.21m
- Cognition Therapeutics funding round, November 2007: $200k